Literature DB >> 16254687

Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review.

B Gerber1, C Scholz, T Reimer, V Briese, W Janni.   

Abstract

Complementary and alternative medicine (CAM) is becoming increasingly popular, particularly among patients with breast cancer. We have done a systematic review of studies published between 1995 and February 2005, identified through a comprehensive search. CAM encompasses a wide range of treatment modalities, including dietary and vitamin supplements, mind-body approaches, acupuncture, and herbal medicines. The objectives of CAM treatments are diverse: reduction of therapy-associated toxicity, improvement of cancer-related symptoms, fostering of the immune system and even direct anticancer effects. Clinical trials have generated few or no data on the efficacy of CAM, whether regarding disease recurrence, survival, overall quality of life or safety. Some CAM methods may even have adverse effects or reduce the efficacy of conventional treatment. The primary justification for CAM is based on empirical evidence, case studies, and hypothetical physiological effects. We conclude that available data on CAM modalities in the treatment of early-stage breast cancer does not support their application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16254687     DOI: 10.1007/s10549-005-9005-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  30 in total

1.  Doc, I don't want your poison.

Authors:  Francesca Giorgi; Romeo Bascioni
Journal:  Oncologist       Date:  2012-06-11

2.  Isoflavones - Mechanism of Action and Impact on Breast Cancer Risk.

Authors:  Johannes Stubert; Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

3.  Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Authors:  Leanna J Standish; Erin Sweet; Eleonora Naydis; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2012-06-27       Impact factor: 3.279

Review 4.  Complementary and alternative therapies used by Turkish breast cancer patients undergoing chemotherapy.

Authors:  Gulbeyaz Can; Melike Demir; Adnan Aydiner
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

5.  Traditional Chinese medicine use among Chinese immigrant cancer patients.

Authors:  Jennifer C F Leng; Francesca Gany
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

6.  Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology.

Authors:  C C Hack; N B M Hüttner; P A Fasching; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

7.  Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.

Authors:  Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay
Journal:  J Womens Health (Larchmt)       Date:  2012-10-17       Impact factor: 2.681

8.  Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells.

Authors:  Chong-Zhi Wang; Han H Aung; Bin Zhang; Shi Sun; Xiao-Li Li; Hui He; Jing-Tian Xie; Tong-Chuan He; Wei Du; Chun-Su Yuan
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

9.  Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo.

Authors:  Young H Ju; Daniel R Doerge; Kellie A Woodling; James A Hartman; Jieun Kwak; William G Helferich
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

10.  Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer.

Authors:  Juliann Saquib; Barbara A Parker; Loki Natarajan; Lisa Madlensky; Nazmus Saquib; Ruth E Patterson; Vicky A Newman; John P Pierce
Journal:  Complement Ther Med       Date:  2012-04-27       Impact factor: 2.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.